FIELD: organic chemistry, chemical technology, medicine, pharmacy.
SUBSTANCE: invention relates to enantiomerically pure esters, namely to enantiomers with (3R,2'R)-, (3S,2'R)-, (3R,2'S)- and (3S,2'S)-configuration of the general formula (I):
wherein R1 means monocyclic saturated (C5-C7)-cycloalkyl residue substituted, if necessary, with one or some (C1-C3)-alkyl residues or one or some halogen atoms, such as fluorine, chlorine, bromine and iodine; R2 means (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl residue that can be substituted, if necessary, with one or some halogen atoms, such as fluorine, chlorine, bromine or iodine; R3 means (C1-C3)-alkyl residue; n means a whole number 1 or 2; AR means phenyl residue or 5-membered ring comprising sulfur as a heteroatom that can be substituted with one or some alkyl (C1-C3)-alkyl groups, groups CF3, CN, NH2, NO2, alkoxy-groups and/or one or some similar or different halogen atoms; A means anion of pharmacologically acceptable acid and wherein OH, AR and R1 groups are placed by clockwise from center of quaternary carbon atom to carboxyl group. Compounds of the formula (I) can be used as a medicinal agent used for treatment of obstructive diseases in respiratory ways, in particular, asthma and chronic bronchitis. Invention describes a method for preparing compounds of the formula (I).
EFFECT: improved preparing method, valuable medicinal properties of compounds.
11 cl, 5 tbl, 2 dwg, 19 ex
Title | Year | Author | Number |
---|---|---|---|
FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
DERIVATIVES OF QUINUCLIDINEAMIDE, METHOD FOR THEIR PREPARING AND THEIR USING, PHARMACEUTICAL COMPOSITION, COMBINED PRODUCT AND METHOD FOR INHIBITION OF MUSCARINIC RECEPTORS | 2003 |
|
RU2314306C2 |
METHOD OF OBTAINING OF GLYCOPYRRONIUM STEREOISOMER OF RR (OR SS)-CONFIGURATION | 2003 |
|
RU2337096C2 |
METHOD OF PRODUCING PYRROLIDINIUM SALTS | 2010 |
|
RU2554878C2 |
CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2686117C1 |
4-AMINOPYPERIDINE DERIVATIVES | 2005 |
|
RU2396257C2 |
METHOD OF PRODUCTION OF MEVALONIC ACID DERIVATIVES INHIBITING HMG-COA REDUCTASE | 2003 |
|
RU2335500C2 |
INTERMEDIATE PRODUCTS FOR PRODUCING NEUTRAL ENDOPEPTIDASE INHIBITORS AND METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2564024C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
COMPOSITIONS CONTAINING BENZOPIPERAZINE AS BROMODOMAIN BET INHIBITORS | 2014 |
|
RU2720237C2 |
Authors
Dates
2004-10-27—Published
1997-11-11—Filed